公司資料
GeneDx 股價、新聞與催化劑
- 股票代碼:
- WGS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
87.06 USD (+5.47%)
收盤價
最後更新: 2026年8月21日
1.58B USD
市值
股價為何變動
As of Aug 21, 2026, WGS closed up 5.47% at $87.06. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
GeneDx is a genomics diagnostics company focused on rare-disease testing, exome sequencing, and clinical genetics. Its business helps clinicians diagnose difficult genetic conditions more efficiently.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, GeneDx sits in molecular diagnostics and genomics.
商業模式特徵
The company depends on test adoption, reimbursement, and the expansion of genomic testing across clinical settings.
生技產業定位
GeneDx is a diagnostics platform name whose stock is driven by adoption, reimbursement, and workflow scale.
未來催化劑
- GeneDx’s catalysts are exome and genome testing volumes, reimbursement, and whether the rare-disease diagnostics franchise keeps expanding. The next update matters because the company’s value is still tied to workflow adoption and test mix.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。